Bristol-Myers Squibb has announced that Giovanni Caforio, its CEO since May 2015, will step down on November 1st. He will continue to lead BMS’ board as executive chairman for a transitional period. Included in BMS’ announcement was Chris Boerner, Chief Commercialization Officer, will become the new CEO.
Click here to read the entire article.